Jiyansh Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 3.27 Cr
as on 24-10-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 44.42 Cr
as on 24-10-2024
- Revenue %
(FY 2023)
- Profit -198.68%
(FY 2023)
- Ebitda -20.53%
(FY 2023)
- Net Worth 17.37%
(FY 2023)
- Total Assets 188.29%
(FY 2023)
About Jiyansh Healthcare
The Corporate was formerly known as Jiyans Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.27 Cr.
The company currently has active open charges totaling ₹44.42 Cr.
Vinubhai Dobaria, Chandrikaben Dobaria, Prashant Nandaniya, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232GJ2007PTC050803
- Company No.
050803
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jiyansh Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinubhai Dobaria  | Director | 11-May-2007 | Current |
| Chandrikaben Dobaria | Director | 03-Jul-2017 | Current |
| Prashant Nandaniya | Director | 03-Jul-2017 | Current |
| Krishna Dobaria | Director | 08-Dec-2022 | Current |
Financial Performance of Jiyansh Healthcare.
Jiyansh Healthcare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 198.68% decrease in profit. The company's net worth Soared by an impressive increase of 17.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jiyansh Healthcare?
In 2023, Jiyansh Healthcare had a promoter holding of 74.00% and a public holding of 26.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mahrshee Organics Private LimitedActive 10 years 6 monthsVinubhai Dobaria and Chandrikaben Dobaria are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 05 Sep 2022 | ₹14.00 Cr | Open |
Axis Bank Limited Creation Date: 26 Aug 2022 | ₹14.00 Cr | Open |
Hdfc Bank Limited Creation Date: 11 Mar 2022 | ₹16.42 Cr | Open |
How Many Employees Work at Jiyansh Healthcare?
Unlock and access historical data on people associated with Jiyansh Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jiyansh Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jiyansh Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
